Advertisement

Neurological Sciences

, Volume 38, Issue 10, pp 1753–1760 | Cite as

Thymectomy is a beneficial therapy for patients with non-thymomatous ocular myasthenia gravis: a systematic review and meta-analysis

  • Kai Zhu
  • Jiaoxing Li
  • Xin Huang
  • Wei Xu
  • Weibin Liu
  • Jiaxin Chen
  • Pei Chen
  • Huiyu FengEmail author
Original Article

Abstract

Ocular myasthenia gravis, an autoimmune disease, is characterized by extraocular muscle weakness. Myasthenia gravis is closely associated with the functional status of the thymus gland. The efficacy of thymectomy for non-thymomatous ocular myasthenia gravis remains controversial. Here, we present the first systematic review and meta-analysis of studies assessing the outcome of thymectomy in patients with non-thymomatous ocular myasthenia gravis and found that the pooled rate of complete stable remission was 0.5074 with considerable heterogeneity. Furthermore, subgroup analysis showed that the efficacy of thymectomy differed according to geographical location. Furthermore, thymectomy outcomes are better in children than they are in adults. Thymectomy clearly represents an effective treatment for patients with non-thymomatous ocular myasthenia gravis. However, more multicenter, randomized, controlled clinical trials are now required to confirm these conclusions.

Keywords

Ocular Myasthenia gravis Thymectomy Non-thymomatous Meta-analysis 

Notes

Acknowledgments

This work was supported by the Project of Guangzhou Science Technology and Innovation Commission (grant number 201605122112149), the Undergraduate teaching reform project of Sun-Yat Sen university (grant number 8000031911105), and Guangdong graduate education innovation program (grant number 2015QTLXXM05).

Compliance with ethical standards

Conflicts of interest

The authors declare that they have no conflict of interest.

References

  1. 1.
    Gilhus NE, Skeie GO, Romi F et al (2016) Myasthenia gravis—autoantibody characteristics and their implications for therapy. Nat Rev Neurol 12:259–268. doi: 10.1038/nrneurol.2016.44 CrossRefPubMedGoogle Scholar
  2. 2.
    Gilhus NE, Verschuuren JJ (2015) Myasthenia gravis: subgroup classification and therapeutic strategies. Lancet Neurol 14:1023–1036CrossRefPubMedGoogle Scholar
  3. 3.
    Bever CTJ, Aquino AV, Penn AS et al (1983) Prognosis of ocular myasthenia. Ann Neurol 14:516–519CrossRefPubMedGoogle Scholar
  4. 4.
    Liu WB (2011) Ocular myasthenia gravis research progress and clinical problems. Chin J Neuroimmunol Neurol 5:314–316Google Scholar
  5. 5.
    Cea G, Benatar M, Verdugo RJ, Salinas RA (2013) Thymectomy for non-thymomatous myasthenia gravis. Cochrane Database Syst Rev CD008111. doi: 10.1002/14651858.CD008111.pub2
  6. 6.
    Yang DS, Nakahara K, Ohno K et al (1989) The result of extended thymectomy in patients with myasthenia gravis of pure ocular type. Nihon Kyobu Geka Gakkai Zasshi 37:313–317PubMedGoogle Scholar
  7. 7.
    Schumm F, Wietholter H, Fateh-Moghadam A, Dichgans J (1985) Thymectomy in myasthenia with pure ocular symptoms. J Neurol Neurosurg Psychiatry 48:332–337CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Kodama H, Yoshida I, Iijima T et al (1993) Effect of extended thymectomy in myasthenia gravis of pure ocular type. Kyobu Geka 46:1017–1020PubMedGoogle Scholar
  9. 9.
    Mineo TC, Ambrogi V (2013) Outcomes after thymectomy in class I myasthenia gravis. J Thorac Cardiovasc Surg 145:1319–1324CrossRefPubMedGoogle Scholar
  10. 10.
    Kawaguchi N, Kuwabara S, Nemoto Y et al (2004) Treatment and outcome of myasthenia gravis: retrospective multi-center analysis of 470 Japanese patients, 1999-2000. J Neurol Sci 224:43–47CrossRefPubMedGoogle Scholar
  11. 11.
    Papatestas AE, Genkins G, Kornfeld P et al (1987) Effects of thymectomy in myasthenia gravis. Ann Surg 206:79–88CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Moher D, Liberati A, Tetzlaff J, Altman DG (2010) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg 8:336–341. doi: 10.1016/j.ijsu.2010.02.007 CrossRefPubMedGoogle Scholar
  13. 13.
    Jaretzki AR, Barohn RJ, Ernstoff RM et al (2000) Myasthenia gravis: recommendations for clinical research standards. Task force of the medical scientific advisory Board of the Myasthenia Gravis Foundation of America. Neurology 55:16–23CrossRefPubMedGoogle Scholar
  14. 14.
    Osserman KE, Genkins G (1971) Studies in myasthenia gravis: review of a twenty-year experience in over 1200 patients. Mt Sinai J Med 38:497–537PubMedGoogle Scholar
  15. 15.
    Stroup DF, Berlin JA, Morton SC et al (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group. JAMA 283:2008–2012CrossRefPubMedGoogle Scholar
  16. 16.
    Vandenbroucke JP, von Elm E, Altman DG et al (2014) Strengthening the reporting of observational studies in epidemiology (STROBE): explanation and elaboration. Int J Surg 12:1500–1524. doi: 10.1016/j.ijsu.2014.07.014 CrossRefPubMedGoogle Scholar
  17. 17.
    O’Connor AM, Sargeant JM, Dohoo IR et al (2016) Explanation and elaboration document for the STROBE-vet statement: strengthening the reporting of observational studies in epidemiology—veterinary extension. Zoonoses Public Health 63:662–698. doi: 10.1111/zph.12315 CrossRefPubMedGoogle Scholar
  18. 18.
    Schwarzer G 2006 Meta-analysis of single proportions. http://artax.karlin.mff.cuni.cz/r-help/library/meta/html/metaprop.html. Accessed 26 May 2017
  19. 19.
    Luo ML, Tan HZ, Zhou Q et al (2013) Reallizing the meta-analysis of single rate in R software. J Evid Based Med 3:181–184,188Google Scholar
  20. 20.
    Masaoka A, Yamakawa Y, Niwa H et al (1996) Extended thymectomy for myasthenia gravis patients: a 20-year review. Ann Thorac Surg 62:853–859CrossRefPubMedGoogle Scholar
  21. 21.
    Nakamura H, Taniguchi Y, Suzuki Y et al (1996) Delayed remission after thymectomy for myasthenia gravis of the purely ocular type. J Thorac Cardiovasc Surg 112:371–375CrossRefPubMedGoogle Scholar
  22. 22.
    Ti T, Ji ZD, Yan SP et al (1996) Surgery of ocular myasthenia gravis in children. Chin J Ped Surg 17:360Google Scholar
  23. 23.
    Chen JM, Jiang YG, Shizhi F et al (2000) Surgical treatment of myasthenia gravis in children. Chin J Clin Thorac Cardiovasc Surg 1:10–12Google Scholar
  24. 24.
    Roberts PF, Venuta F, Rendina E et al (2001) Thymectomy in the treatment of ocular myasthenia gravis. J Thorac Cardiovasc Surg 122:562–568CrossRefPubMedGoogle Scholar
  25. 25.
    Singh RS, Behera SK, Saji R, Dhaliwal RS (2003) Thymectomy for myasthenia gravis: 12-year experience. Asian Cardiovasc Thorac Ann 11:299–303CrossRefPubMedGoogle Scholar
  26. 26.
    Tansel T, Onursal E, Barlas S et al (2003) Results of surgical treatment for nonthymomatous myasthenia gravis. Surg Today 33:666–670CrossRefPubMedGoogle Scholar
  27. 27.
    Zielinski M, Kuzdzal J, Szlubowski A, Soja J (2004) Comparison of late results of basic transsternal and extended transsternal thymectomies in the treatment of myasthenia gravis. Ann Thorac Surg 78:253–258CrossRefPubMedGoogle Scholar
  28. 28.
    Zhang CB, Zheng J, Wang Q et al (2004) Treatment of 20 ocular myasthenia gravis cases. J Zhengzhou Univ 39:914–915Google Scholar
  29. 29.
    Tan QY, Wang RW, Jiang YG et al (2004) Long-term outcome and relevant factors of thymectomy for myasthenia gravis in children. Chin J Surg 2:177–178Google Scholar
  30. 30.
    Lu JJ, Zhong FT, Li XR et al (2004) Surgical treatment of myasthenia gravis in children. Guangdong Med J 4:430–431Google Scholar
  31. 31.
    Rea F, Marulli G, Bortolotti L et al (2006) Experience with the “da Vinci” robotic system for thymectomy in patients with myasthenia gravis: report of 33 cases. Ann Thorac Surg 81:455–459CrossRefPubMedGoogle Scholar
  32. 32.
    Wang H, Zhou L, Gao Y et al (2007) Thymectomy of myasthenia gravis in children. J Brain Nerv Dis 2:134–135Google Scholar
  33. 33.
    Luo LQ, Zhang JZ, Cui HN et al (2008) Clinical analysis of thymectomy for juvenile with myasthenia gravis. China J Mod Med 15:2202–2204Google Scholar
  34. 34.
    Prokakis C, Koletsis E, Salakou S et al (2009) Modified maximal thymectomy for myasthenia gravis: effect of maximal resection on late neurologic outcome and predictors of disease remission. Ann Thorac Surg 88:1638–1645CrossRefPubMedGoogle Scholar
  35. 35.
    Pompeo E, Tacconi F, Massa R et al (2009) Long-term outcome of thoracoscopic extended thymectomy for nonthymomatous myasthenia gravis. Eur J Cardiothorac Surg 36:164–169CrossRefPubMedGoogle Scholar
  36. 36.
    Deng Y, Zhang X (2009) Prognosis of thymectomy in treatment of ocular myasthenia gravis and relevant influencing factors. Natl Med J China 89:1922–1925Google Scholar
  37. 37.
    Lin MW, Chang YL, Huang PM, Lee YC (2010) Thymectomy for non-thymomatous myasthenia gravis: a comparison of surgical methods and analysis of prognostic factors. Eur J Cardiothorac Surg 37:7–12CrossRefPubMedGoogle Scholar
  38. 38.
    Xie SP, Jie H (2010) The analysis of thymectomy for pure ocular myasthenia gravis in children. J Clin Surg 18:40–41Google Scholar
  39. 39.
    Liu Z, Feng H, Yeung SC et al (2011) Extended transsternal thymectomy for the treatment of ocular myasthenia gravis. Ann Thorac Surg 92:1993–1999CrossRefPubMedGoogle Scholar
  40. 40.
    Cheng C, Liu Z, Xu F et al (2013) Clinical outcome of juvenile myasthenia gravis after extended transsternal thymectomy in a Chinese cohort. Ann Thorac Surg 95:1035–1041CrossRefPubMedGoogle Scholar
  41. 41.
    Huang CS, Li WY, Lee PC et al (2014) Analysis of outcomes following surgical treatment of thymolipomatous myasthenia gravis: comparison with thymomatous and non-thymomatous myasthenia gravis. Interact Cardiovasc Thorac Surg 18:475–481CrossRefPubMedGoogle Scholar
  42. 42.
    Yan L, Liu WB et al (2012) Response to thymectomy and analysis of influencing factors in the treatment of children with myasthenia gravis. Zhonghua Yi Xue Za Zhi 92:1170–1173Google Scholar
  43. 43.
    Mineo TC, Ambrogi V, Schillaci O (2014) May positron emission tomography reveal ectopic or active thymus in preoperative evaluation of non-thymomatous myasthenia gravis? J Cardiothorac Surg 9:146CrossRefPubMedPubMedCentralGoogle Scholar
  44. 44.
    Ware TL, Ryan MM, Kornberg AJ (2012) Autoimmune myasthenia gravis, immunotherapy and thymectomy in children. Neuromuscul Disord 22:118–121CrossRefPubMedGoogle Scholar
  45. 45.
    Wolfe GI, Kaminski HJ, Aban IB et al (2016) Randomized trial of thymectomy in myasthenia gravis. N Engl J Med 375:511–522. doi: 10.1056/NEJMoa1602489 CrossRefPubMedPubMedCentralGoogle Scholar
  46. 46.
    Kaufman AJ, Palatt J, Sivak M et al (2016) Thymectomy for myasthenia gravis: complete stable remission and associated prognostic factors in over 1000 cases. Semin Thorac Cardiovasc Surg 28:561–568. doi: 10.1053/j.semtcvs.2016.04.002 CrossRefPubMedGoogle Scholar
  47. 47.
    Kang SY, Oh JH, Song SK et al (2015) Both binding and blocking antibodies correlate with disease severity in myasthenia gravis. Neurol Sci 36:1167–1171. doi: 10.1007/s10072-015-2236-8 CrossRefPubMedGoogle Scholar
  48. 48.
    Feng H-Y, Wang H-Y, Liu W-B et al (2013) The high frequency and clinical feature of seronegative myasthenia gravis in southern China. Neurol Sci 34:919–924. doi: 10.1007/s10072-012-1159-x CrossRefPubMedGoogle Scholar
  49. 49.
    Huang X, Liu WB, Men LN et al (2013) Clinical features of myasthenia gravis in southern China: a retrospective review of 2,154 cases over 22 years. Neurol Sci 34:911–917. doi: 10.1007/s10072-012-1157-z CrossRefPubMedGoogle Scholar
  50. 50.
    Wang W, Chen YP, Wang ZK et al (2013) A cohort study on myasthenia gravis patients in China. Neurol Sci 34:1759–1764. doi: 10.1007/s10072-013-1329-5 CrossRefPubMedGoogle Scholar
  51. 51.
    Benatar M, Sanders DB, Wolfe GI et al (2012) Design of the efficacy of prednisone in the treatment of ocular myasthenia (EPITOME) trial. Ann N Y Acad Sci 1275:17–22. doi: 10.1111/j.1749-6632.2012.06780.x CrossRefPubMedGoogle Scholar
  52. 52.
    Friedant AJ, Handorf EA, Su S, Scott WJ (2016) Minimally invasive versus open thymectomy for thymic malignancies: systematic review and meta-analysis. J Thorac Oncol 11:30–38. doi: 10.1016/j.jtho.2015.08.004 CrossRefPubMedGoogle Scholar
  53. 53.
    Yang Y, Dong J, Huang Y (2016) Thoracoscopic thymectomy versus open thymectomy for the treatment of thymoma: a meta-analysis. Eur J Surg Oncol 42:1720–1728. doi: 10.1016/j.ejso.2016.03.029 CrossRefPubMedGoogle Scholar
  54. 54.
    Gung Y, Zhang H, Li S, Wang Y (2016) Sternotomy versus video-assisted thoracoscopic surgery for thymectomy of myasthenia gravis patients: a meta-analysis. Asian J Endosc Surg 9:285–294. doi: 10.1111/ases.12300 CrossRefPubMedGoogle Scholar
  55. 55.
    Okusanya OT, Hess N, Christie N et al (2016) Improved outcomes with surgery vs. medical therapy in non-thymomatous myasthenia gravis: a perspective on the results of a randomized trial. Ann Transl Med 4:526. doi: 10.21037/atm.2016.12.54 CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer-Verlag Italia S.r.l. 2017

Authors and Affiliations

  1. 1.Department of Neurology, the First Affiliated HospitalSun Yat-sen UniversityGuangzhouChina
  2. 2.Guangdong Provincial Key Laboratory for Diagnosis and Treatment of Major Neurological DiseaseGuangdongChina

Personalised recommendations